UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 75

Sortiert nach

Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting

Journal of the American College of Cardiology, 2017-04, Vol.69 (16), p.2011-2022

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of immature platelets on platelet response to ticagrelor and prasugrel in patients with acute coronary syndrome

European heart journal, 2015-12, Vol.36 (45), p.3202-3210

2015

Link zum Volltext

Verfügbarkeit prüfen

Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial

JAMA : the journal of the American Medical Association, 2014-11, Vol.312 (19), p.1981

2014

Link zum Volltext

Verfügbarkeit prüfen

Ticagrelor or Prasugrel in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes

Journal of the American College of Cardiology, 2020-11, Vol.76 (21), p.2436-2446

2020

Link zum Volltext

Verfügbarkeit prüfen

Gender balance at the heart of science

Cardiovascular research, 2020-08, Vol.116 (10), p.e115-e117

2020

Link zum Volltext

Verfügbarkeit prüfen

Increased bleeding risk during percutaneous coronary interventions by arterial hypertension

Catheterization and cardiovascular interventions, 2016-08, Vol.88 (2), p.184-190

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Ticagrelor Versus Prasugrel in Women and Men with Acute Coronary Syndrome: A Pre-specified, Sex-Specific Analysis of the ISAR-REACT 5 Trial

Journal of Atherosclerosis and Thrombosis, 2022/05/01, Vol.29(5), pp.747-761

2022

Link zum Volltext

Verfügbarkeit prüfen

Association of Progression or Regression of Coronary Artery Atherosclerosis with Long-term Prognosis

The American heart journal, 2016-07, Vol.177, p.9-16

2016

Link zum Volltext

Verfügbarkeit prüfen

Assessment of Impact of Patient Recruitment Volume on Risk Profile, Outcomes, and Treatment Effect in a Randomized Trial of Ticagrelor Versus Prasugrel in Acute Coronary Syndromes

Journal of the American Heart Association, 2021-11, Vol.10 (22), p.e021418-e021418

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of Dabigatran versus Phenprocoumon on ADP Induced Platelet Aggregation in Patients with Atrial Fibrillation with or without Concomitant Clopidogrel Therapy (the Dabi-ADP-1 and Dabi-ADP-2 Trials)

BioMed research international, 2015-01, Vol.2015, p.798486-10

2015

Link zum Volltext

Verfügbarkeit prüfen

Mechanistic insights into the superior clinical efficacy of prasugrel over ticagrelor

European heart journal, 2020-09, Vol.41 (33), p.3153-3155

2020

Link zum Volltext

Verfügbarkeit prüfen

Ticagrelor or Prasugrel in Acute Coronary Syndromes. Reply

The New England journal of medicine, 2020-01, Vol.382 (5), p.487-487

2020

Link zum Volltext

Verfügbarkeit prüfen

Less myocardial scar but greater propensity for heart failure: another gender paradox in myocardial infarction

European heart journal, 2017-06, Vol.38 (21), p.1664-1665

2017

Link zum Volltext

Verfügbarkeit prüfen

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial

Journal of the American College of Cardiology, 2015-04, Vol.65 (16), p.1619-1629

2015

Link zum Volltext

Verfügbarkeit prüfen

Round‐knit or flat‐knit compression garments for maintenance therapy of lymphedema of the leg? – Review of the literature and technical data

Journal der Deutschen Dermatologischen Gesellschaft, 2019-08, Vol.17 (8), p.775-784

2019

Link zum Volltext

Verfügbarkeit prüfen

Safety of a compression stocking for patients with chronic venous insufficiency (CVI) and peripheral artery disease (PAD)

Journal der Deutschen Dermatologischen Gesellschaft, 2020-03, Vol.18 (3), p.207-213

2020

Link zum Volltext

Verfügbarkeit prüfen

Ticagrelor or Prasugrel for Platelet Inhibition in Acute Coronary Syndrome Patients: The ISAR-REACT 5 Trial

Journal of the American College of Cardiology, 2020-11, Vol.76 (21), p.2569-2571

2020

Link zum Volltext

Verfügbarkeit prüfen

Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes : Results From a Randomized Trial

Annals of internal medicine, 2020-09, Vol.173 (6), p.436

2020

Link zum Volltext

Verfügbarkeit prüfen

Plasma Soluble Glycoprotein VI, Platelet Function, Bleeding, and Ischemic Events in Patients Undergoing Elective Percutaneous Coronary Intervention

Thrombosis and haemostasis, 2024-04, Vol.124 (4), p.297

2024

Link zum Volltext

Verfügbarkeit prüfen

Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI)

European heart journal, 2021-07, Vol.42 (27), p.2630-2642

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 75

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(75)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(62)
Life Sciences & Biomedicine
(61)
Female
(41)
Cardiovascular System & Cardiology
(34)
Male
(34)
Aged
(31)
Middle Aged
(29)
Treatment Outcome
(29)
Cardiac & Cardiovascular Systems
(23)
Percutaneous Coronary Intervention
(20)
Dermatology
(18)
Risk Factors
(14)
Time Factors
(14)
Adult
(13)
Peripheral Vascular Disease
(11)
Platelet Aggregation Inhibitors - Adverse Effects
(11)
Acute Coronary Syndrome - Drug Therapy
(10)
Aged, 80 And Over
(10)
Ticagrelor
(10)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting

Impact of immature platelets on platelet response to ticagrelor and prasugrel in patients with acute coronary syndrome

Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial

Ticagrelor or Prasugrel in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes

Gender balance at the heart of science

Increased bleeding risk during percutaneous coronary interventions by arterial hypertension

Efficacy and Safety of Ticagrelor Versus Prasugrel in Women and Men with Acute Coronary Syndrome: A Pre-specified, Sex-Specific Analysis of the ISAR-REACT 5 Trial

Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients

Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease: The Randomized, Double-blind, Placebo-Controlled ISAR-PLASTER Phase 2 Trial

Association of Progression or Regression of Coronary Artery Atherosclerosis with Long-term Prognosis

Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial

Assessment of Impact of Patient Recruitment Volume on Risk Profile, Outcomes, and Treatment Effect in a Randomized Trial of Ticagrelor Versus Prasugrel in Acute Coronary Syndromes

Impact of Dabigatran versus Phenprocoumon on ADP Induced Platelet Aggregation in Patients with Atrial Fibrillation with or without Concomitant Clopidogrel Therapy (the Dabi-ADP-1 and Dabi-ADP-2 Trials)

Mechanistic insights into the superior clinical efficacy of prasugrel over ticagrelor

Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents

Ticagrelor or Prasugrel in Acute Coronary Syndromes. Reply

Less myocardial scar but greater propensity for heart failure: another gender paradox in myocardial infarction

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial

2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery

Round‐knit or flat‐knit compression garments for maintenance therapy of lymphedema of the leg? – Review of the literature and technical data

Safety of a compression stocking for patients with chronic venous insufficiency (CVI) and peripheral artery disease (PAD)

Ticagrelor or Prasugrel for Platelet Inhibition in Acute Coronary Syndrome Patients: The ISAR-REACT 5 Trial

Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes : Results From a Randomized Trial

Plasma Soluble Glycoprotein VI, Platelet Function, Bleeding, and Ischemic Events in Patients Undergoing Elective Percutaneous Coronary Intervention

Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Aktive Filter

Suchergebnisse filtern